1. 1. Terasaki H, Niki T, Matsuno Y, Ymada T, Maeshima A, Asamura H, Hayabuchi N, Hirohashi S. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol, 27: 937-951, 2003.
2. The new World Health Organization classification of lung tumours
3. 3. Colby TV, Noguchi M, Henschke C, Harris CC. Adenocarcinoma. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organisation classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon, 35-44, 2004.
4. 4. Harrison M, Magee HM, O'Loughlin J, Gorey TF, Dervan PA. Comparison of Chromosome 1 aneusomy detected by interphase cytogenetics and DNA ploidy in carcinoma of the breast. Histopathology, 30: 221-226, 1997.
5. 5. Salih E, Hakan A, Faruk Z, Dilek D, Hadi A, Yücel G, Fikri I. Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer, 33: 109-114, 2001.